Innovations in development for the biosimilar industry
The leading scientific event for biosimilar drug development
Biosimilar Drug Development World provides you with the strategy and science to take biosimilars from bench to market. Come and learn:
• Biosimilar product development, CMC and comparative analysis
• Considerations for biosimilar manufacture, process development, scale-up and validation
• Non clinical studies for biosimilars
• Best practice in clinical trials design and execution
• The use of immunogenicity tools and techniques in development and the clinic
• Proven strategies in biosimilar pharmacovigilance and risk management
• Global regulatory requirements, the resulting impact on drug development, manufacture & clinical trials
The focus for Biosimilar Drug Development World Americas 2012
- Scientific foundations behind the development of biosimilars from the bench to market
- Biosimilar clinical trial requirements, challenges and opportunities
- Manufacturing process development and scale-up
- Biosimilar immunogenicity
- Global regulatory review and analysis
- Industry of tomorrow: How could the regulatory setting alter to improve access
Who should attend
- Formulation
- Development
- Reg Affairs
- Clinical Trials
- Pharmacovigilance
- Preclinical Dev
- Toxicology
- Manufacturing
- Bioequivalence
- CMC
Who should sponsor
• Full Service CRO
• Niche CRO
• Management Consultant
• Contract Manufacturing Organisation
• Clinical/Non Clinical IT Solutions
• Law Firms
There are limited sponsorship opportunities available
Generic Medicines Americas
Biosimilar Drug Development Americas 2012 is co-located with the long running event Generic Medicines World Americas 2012
